| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/16/2005 | CN1582165A Antibodies to CD40 |
| 02/16/2005 | CN1580265A T-20 fusion protein, and its preparing method and use |
| 02/16/2005 | CN1580261A CC10 protein preparation and use |
| 02/16/2005 | CN1580236A Method for producing gamma-linolenic acid protein by biofermentation |
| 02/16/2005 | CN1579195A High-active protein and technology for producing said protein by multiple bacterial-spawn liquid-solid combined fermentation |
| 02/16/2005 | CN1189564C Modulators of the function of receptors of the TNF/NGF receptor family |
| 02/16/2005 | CN1189563C Cloning-free linear expression vector constituting method |
| 02/16/2005 | CN1189557C Detecting and trapping receptor 3 monoclonal antibody, hybrid tumor for producing said antibody and its use |
| 02/16/2005 | CN1189484C Recombined human CD11a monclone antibody and its preparation and medicinal composition |
| 02/16/2005 | CN1189213C Tolerance to xenograft |
| 02/15/2005 | US6855810 Ligands directed to the non-secretory component, non-stalk region of plgR and methods of use thereof |
| 02/15/2005 | US6855809 Chimeric immunoglobulin for detecting hepatitis c viral (HVC) infections and/or contaminated blood products; diagnosis and viral diseases |
| 02/15/2005 | US6855808 Prevent cell differentiation; culture product; genetic engineered protein |
| 02/15/2005 | US6855807 Heterodimeric opioid G-protein coupled receptors |
| 02/15/2005 | US6855806 Comprises secreted polypeptide for diagnosis and treatment of tumors, nervous system, reproductive and muscular disorder |
| 02/15/2005 | US6855803 Protein having hemolytic activity and gene encoding the protein |
| 02/15/2005 | US6855802 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy |
| 02/15/2005 | US6855550 Genetically engineered microorganism for use as tools in the generation of heterologous binding proteins |
| 02/15/2005 | US6855533 Structure-based designed herbicide resistant products |
| 02/15/2005 | US6855520 Cell volume-regulated human kinase h-sgk |
| 02/15/2005 | US6855519 Methods for enhancing the production of interferon in cell culture |
| 02/15/2005 | US6855518 Anti-listeria bacteriocin |
| 02/15/2005 | US6855515 Preparing immune responsive polypeptide fragment with protein kinase c and/or nuclear mitotic apparatus protein activity for diagnosis and treatment of autoimmune diseases |
| 02/15/2005 | US6855365 Recombinant bacterial phytases and uses thereof |
| 02/15/2005 | US6855321 Polyepitope carrier protein |
| 02/15/2005 | US6855318 Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes |
| 02/15/2005 | US6855317 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/10/2005 | WO2005012542A1 Casein hydrolyzate, process for producing the same and use thereof |
| 02/10/2005 | WO2005012541A1 Method for producing cyclic molecules |
| 02/10/2005 | WO2005012532A1 System for the production of dimeric proteins based on the transport system of hemolysin of escherichia coli |
| 02/10/2005 | WO2005012531A2 Antibody cdr polypeptide sequences with restricted diversity |
| 02/10/2005 | WO2005012495A2 Methods for expression and purification of immunotoxins |
| 02/10/2005 | WO2005012492A2 Human skin equivalents expressing exogenous polypeptides |
| 02/10/2005 | WO2005012359A2 Anti-vegf antibodies |
| 02/10/2005 | WO2005012355A1 Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis |
| 02/10/2005 | WO2005012334A1 Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 02/10/2005 | WO2005011580A2 Compositions and methods for herpes simplex prophylaxis and treatment |
| 02/10/2005 | WO2004108906A3 Bacterial carriers for nucleotide sequences coding for active substances |
| 02/10/2005 | WO2004024068A3 Novel composition and methods for the treatment of immune related diseases |
| 02/10/2005 | WO2004003207A9 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 02/10/2005 | WO2003086175A8 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/10/2005 | WO2003060065A3 Adapter-directed display system |
| 02/10/2005 | WO2003030624A3 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 02/10/2005 | WO2003025117A3 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
| 02/10/2005 | WO2002064626A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 02/10/2005 | WO2002020718A3 Osteoclast-associated receptor |
| 02/10/2005 | US20050034190 Transgenic soybean seeds exhibiting an oil composition comprising 55 to 80% by weight oleic acid, 10 to 40% by weight linoleic acid, 6% or less by weight linolenic acid, and 2 to 8% by weight saturated fatty acids for use in ehancing applicability in food, biodiesel and biolube markets |
| 02/10/2005 | US20050033042 Nucleic acids encoding recominant 56 and 82 kda antigens fromn gametocytes of eimeria maxima and their uses |
| 02/10/2005 | US20050033036 An isolated DNA encoding a protein, has testicular differentiation activity |
| 02/10/2005 | US20050033019 Nucleotide sequence coding for a modified protein of interest, expression vector and method for obtaining same |
| 02/10/2005 | US20050033018 Receptors and membrane-associated proteins |
| 02/10/2005 | US20050033017 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/10/2005 | US20050032693 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 02/10/2005 | US20050032223 Generating site directed DNA breaks in transformed cells via expression of heterologous endonuclease; bioreactor for generating exogenous proteins; gene therapy |
| 02/10/2005 | US20050032194 Protease deficient caulobacter host cells |
| 02/10/2005 | US20050032190 Beta-secretase substrates and uses thereof |
| 02/10/2005 | US20050032189 Novel protein derived from agkistrodon saxatilis emelianov and process preparing the same |
| 02/10/2005 | US20050032187 Novel peptide-forming enzyme, microbe producing the enzyme and method for producing peptide using them |
| 02/10/2005 | US20050032175 High affinity fusion proteins and therapeutic and diagnostic methods for use |
| 02/10/2005 | US20050032174 Multimeric protein for use in the treatment and prevention of infection and bleeding disorders |
| 02/10/2005 | US20050032172 Expression vector comprising nucleotide sequences coding tumor necrosis factor (FTHMA-) and/or axon guidance receptor (T85) for use in identifying modulators for prevention and/or treatment of cell proliferative or neurological disorders |
| 02/10/2005 | US20050032170 Expression vector comprising nucleotide sequences coding native sequence-4 (NS4) for use in identifying modulators for treatment and prevention of obesity, cachexia and anorexia |
| 02/10/2005 | US20050032168 17 human secreted proteins |
| 02/10/2005 | US20050032166 Expression vector comprising nucleotide sequences coding adipokine binding protein for use in treatment and prevention of diabetes, obesity, inflammation, cardiovascular and metabolic disorders |
| 02/10/2005 | US20050032161 Novel xanthine phosphoribosyl transferase |
| 02/10/2005 | US20050032155 Expression vector comprising nucleotide sequences coding defective receptor protein for use as model in treatment and prevention of convulsive disorders |
| 02/10/2005 | US20050032154 Using microbial enzyme mixture to generate tripeptides for use in pharmaceuticals and foods |
| 02/10/2005 | US20050032149 Enzyme catalyzed isotope labeling |
| 02/10/2005 | US20050032146 Tssk4: a human testis specific serine/threonine kinase |
| 02/10/2005 | US20050032111 Using intregral membrane protein concentration as diagnostic and/or prognostic indicator of successful pregnancy; in vitro fertilization and reproductive disorders |
| 02/10/2005 | US20050032109 Polypeptide activator for use as tool in treatment of thrombosis; treatment diagnosis of blood disorders |
| 02/10/2005 | US20050032086 Providing cell-free system for use in vitro translation and/or transcription |
| 02/10/2005 | US20050032085 Novel chromophores/fluorophores and methods for using the same |
| 02/10/2005 | US20050032078 Methods for the detection, analysis and isolation of nascent proteins |
| 02/10/2005 | US20050032058 Using aberrant homeobox gene expression in hematopoietic cells as diagnostic indicator of cell proliferfative disorders |
| 02/10/2005 | US20050032047 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay |
| 02/10/2005 | US20050031630 Immunogen (antibody determinant, lipid, peptide, and/or carbohydrate) derived from virus/cancer cell with mast cell membrane activator; microbiocides; wound healing agents; reduced scarring |
| 02/10/2005 | US20050031624 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 02/10/2005 | US20050031623 Blot analysis of urine/serum; proteoglycan-like domains; oncogenes; hybridomas |
| 02/10/2005 | US20050031613 CD 16 antigen; antibody produced by cell unresistant to lectin which recognizes sugar chain in which 1-position of fucose is bound to 6-position of N-acetylglucosamine in the reducing end through alpha -bond in a complex N-glycoside-linked sugar chain; signal transduction |
| 02/10/2005 | US20050031607 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 02/10/2005 | CA2574733A1 Method for the production of cyclic molecules |
| 02/10/2005 | CA2546497A1 Casein hydrolyzate, process for producing the same and use thereof |
| 02/10/2005 | CA2534360A1 Methods for expression and purification of immunotoxins |
| 02/10/2005 | CA2534299A1 System for producing dimeric proteins based on the escherichia coli hemolysin transport system |
| 02/10/2005 | CA2534055A1 Antibody cdr polypeptide sequences with restricted diversity |
| 02/10/2005 | CA2533593A1 Altered antibodies having improved antigen-binding affinity |
| 02/10/2005 | CA2533297A1 Anti-vegf antibodies |
| 02/10/2005 | CA2532537A1 Biologically non-degradable peptides and their use as angiotensin converting enzyme inhibitors, drugs and functional foods |
| 02/09/2005 | EP1505153A1 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 02/09/2005 | EP1505150A1 Novel proteins and dnas thereof |
| 02/09/2005 | EP1505149A1 Methylotroph producing mammalian type sugar chain |
| 02/09/2005 | EP1505148A1 Methods of screening for agonistic antibodies |
| 02/09/2005 | EP1505075A1 Antibody to human insulin-like growth factor |
| 02/09/2005 | EP1504764A1 Treatment of liver fibrosis with antagonists of alpha V beta 6 integrin |
| 02/09/2005 | EP1504111A2 Nucleic acid-peptide display libraries containing peptides with unnatural amino acid residues, and methods of making same |
| 02/09/2005 | EP1504098A2 A method for in vitro molecular evolution of protein function |
| 02/09/2005 | EP1504097A2 Protein interaction system for multisubunit complexes |
| 02/09/2005 | EP1504035A2 Antibodies specific for human cd22 and their therapeutic and diagnostic uses |
| 02/09/2005 | EP1504027A2 Adipocyte complement related protein zacrp8 |